Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity

The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are: * Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure? * What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity? Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure. Participants will: * Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA * Undergo pulmonary function tests and sampling of blod and urin before and after each session * Serve as their own controls in a double-blind, randomized, crossover study design

Participants needed: 32
Trial details
Age: 20-64Biological sex: AllType: InterventionalSponsor: Blekinge Institute of TechnologyUpdated: Dec 4, 2025Locations: 2
Eligibility criteria

Military divers actively serving, aged 20-64 years [+1]

Ongoing infection or illness that may impact pulmonary function [+5]

Status: Not yet recruiting

Non-invasive Diagnosis of Parkinson's Disease

This study will investigate new, non-invasive methods to help diagnose Parkinson's disease. Researchers will use advanced eye imaging (hyperspectral retinal photography and OCT), computerized memory and thinking tests, and voice analysis to identify patterns linked to Parkinson's. The goal is to improve early and accurate diagnosis of Parkinson's disease without the need for spinal taps or invasive tests.

Participants needed: 60
Trial details
Age: 60-80Biological sex: AllType: ObservationalSponsor: Blekinge Institute of TechnologyUpdated: Oct 1, 2025
Eligibility criteria

Age 60-80 years [+9]

At least one eye must not have retinal disease, glaucoma, or vascular eye diseas... [+8]

Status: Not yet recruiting

The Effect of Regular Home Use of Dual-light Antibacterial Photodynamic Therapy (aPDT) or the Use of a Powered Toothbrush in Older Individuals With Periodontitis and Mild Cognitive Impairment.

Objective: To compare three different oral hygiene regimens regarding plaque index (PI), bleeding on probing (BOP), the number of deepened periodontal pockets ≥4 mm (PPD), oral halitosis, and changes in oral health-related quality of life (OHRQoL) in an older population with periodontitis stage I-III and mild cognitive impairment. 1. Are there improvements in plaque index (PI), number of bleeding on probing (BOP) sites, number of probing depths (PPD), and intraoral halitosis in the two test groups compared to the control group? 2. Do the study interventions affect oral health-related quality of life in older adults with periodontitis and mild cognitive impairment? Study design: Type: Randomized controlled trial Duration: 6 months per participant, 2 years in total for data collection Participants: 90 participants divided into Intervention and Control groups Intervention Group A (Lumoral Dual-Light aPDT + Manual Toothbrush) Standardized oral hygiene instructions and the use of a manual toothbrush during the test period, with an adjunctive aPDT device (Lumoral®). Intervention Group B (Oral-B iO Powered Toothbrush) Standardized oral hygiene instructions and the use of an Oral-B iO powered toothbrush during the test period. Control Group Standardized oral hygiene instructions and the use of a manual TePe Select extra soft toothbrush during the test period.

Participants needed: 90
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Blekinge Institute of TechnologyUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

Adults aged ≥60 years [+4]

Antibiotic use (within 3 months) [+3]

Status: Not yet recruiting

Evening Screen Content and Sleep Architecture in Older Adults: Crossover RCT

Title The Effect of Evening Technology Use with Calming vs. Exciting Content on Sleep Architecture in Older Adults: A Crossover Randomized Controlled Trial Background The study explores how evening use of digital devices with different types of content (calming vs. exciting) affects sleep in older adults. While technology's effects on sleep have been studied in younger populations, its specific impacts on older adults remain under-researched. This study fills that gap by focusing on subjective and objective sleep measures. Objectives and Research Questions Objective: Compare the effects of calming digital content, exciting digital content, and non-digital activities on sleep architecture. Key Questions: How does content type impact sleep architecture and quality? Does calming content lead to better sleep outcomes than exciting content? Are there subjective differences in sleep quality across conditions?

Participants needed: 50
Trial details
Age: 60-75Biological sex: AllType: InterventionalSponsor: Blekinge Institute of TechnologyUpdated: Jun 3, 2025Locations: 1
Eligibility criteria

Age 60 - 75 years [+2]

Diagnosed sleep disorder [+2]

Status: Not yet recruiting

Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning

This study aims to explore the potential of using machine learning (ML) algorithms to predict Diabetes type2, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting type 2 diabetes in individuals with mild cognitive impairment aged 60 and above.

Participants needed: 2,000
Trial details
Age: 60+Biological sex: AllType: ObservationalSponsor: Blekinge Institute of TechnologyUpdated: May 20, 2025Locations: 1Duration: 1 Day
Eligibility criteria

Individuals aged 60 years or older. [+1]

Status: Recruiting

A Digital Life Story to Support Person-centred Care for Older Adults With Dementia Perspectives

Person-centred care can be supported when healthcare professionals access and actively use the information recorded in a life story. Active use of the life story can create security for a person with dementia and their carers. The written life story describes the person and their life experiences, which can define the person's identity. National guidelines for care and nursing in dementia and Blekinge's regional guidelines emphasise the importance of care and nursing for people with dementia, which should be given with a person-centred approach, where the life story becomes a tool for healthcare professionals. Research shows that a life story can be designed in several ways. For example, in book form, as a brochure, collage, memory box or electronically. The life story is also intended as a tool for healthcare professionals to create security and facilitate communication with the individual. As more and more older adults are using computers and tablets as assistive devices, and it is also becoming more common for healthcare professionals to use, for example, tablets as assistive devices in nursing care, the life story could be shared in digital form as an application and become a living document. Overall aim: To test an application for the life story with the intention of supporting person-centred care for older adults with dementia and to test whether the application can replace the written completion document. Study I: Exploring the research area of the life story in digital form. Study II: Focus group interviews with healthcare professionals. Study III: Test the application, Min Memoria. Study IV: Observations on the use of the application.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Blekinge Institute of TechnologyUpdated: Mar 29, 2024Locations: 1
Eligibility criteria

Healthcare professionals using a life story in daily care.

N/A